Mr. Chu Wai Tsun, Baggio (朱維馴), initially joined our Group in July 2010 as the financial controller of Eternal Far East until March 2020. Mr. Chu re-joined our Group in May 2023 as the chief financial officer. He was appointed as a Director on July 10, 2024 and re-designated as an executive Director on July 12, 2024. He is primarily responsible for overall financial management and investors relationship affairs of our Group.
Mr. Chu has long been engaged in auditing and financing, and has rich experience in investment and financial management. From May 2002 to February 2005, Mr. Chu worked in H.K. Zhong Tian Hua Zheng CPA Ltd. with his last position as semi senior audit assistant. From April 2005 to December 2008, he worked in PricewaterhouseCoopers with his last position as a manager. From January 2009 to June 2010, he worked as a senior audit manager in UHY Vocation HK CPA Limited. From March 2020 to September 2021, he worked as senior financial director in Sipai Health Technology Co., Ltd. (思派健康科技有限公司), a medical and health services company currently listed on the Stock Exchange (stock code: 314). From September 2021 to December 2022, he worked as vice president of finance in Shenzhou Medical Technology Co., Ltd (神州醫療科技股份有限公司). From March 2012 to June 2018 and since June 2021, Mr. Chu was and has been an independent non-executive director of Nanjing Panda Electronics Company Limited (南京熊貓電子股份有限公司), an electronic equipment company currently listed on the Stock Exchange (stock code: 553) and Shanghai Stock Exchange (stock code: 600775).
Mr. Chu was admitted as an associate of CPA Australia in January 2001. He obtained the master’s degree of commerce in finance at the University of New South Wales in Australia in June 2002 and a bachelor’s degree of business at the University of Technology, Sydney in October 2000.
